HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.

Abstract
Mantle cell lymphoma (MCL) is an aggressive lymphoid tumour characterized by the translocation t(11;14)(q13;q32) and a poor clinical outcome (median survival: 3-4 years). Recent studies revealed that increased proliferation of the tumour cells and certain chromosomal aberrations, such as deletions of 17p13 and 9p21 represent major adverse biological markers in this disease, although the molecular targets of chromosomal imbalances in MCL have not been identified for the large majority of loci affected. To correlate histomorphological and proliferation features of MCL with genetic findings, we investigated 223 MCL by fluorescence in situ hybridization (FISH) (n = 157) and/or classical cytogenetic banding analysis (n = 129). FISH analysis turned out to be distinctly more sensitive in the delineation of aberrations. Complex karyotypic alterations were associated with higher proliferation indices and inferior prognosis. A comprehensive analysis of biological features including genetic alterations in MCL by hierarchical clustering resulted in the delineation of four tumour subgroups differing with respect to their genetic constitution and suggesting different transformation or progression pathways. Moreover, in one of the groups identified, a more indolent clinical behaviour was associated with few secondary aberrations and fewer known high-risk chromosomal aberrations, which points to the importance of the quality of karyotypic evolution in MCL tumours.
AuthorsTiemo Katzenberger, Dirk Kienle, Stephan Stilgenbauer, Sylvia Höller, Carolin Schilling, Uwe Mäder, Bernhard Puppe, Celine Petzoldt, Sandrine Sander, Lars Bullinger, Heike Stöcklein, Jörg Kalla, Elena Hartmann, Patrick Adam, M Michaela Ott, Hans-Konrad Müller-Hermelink, Andreas Rosenwald, German Ott
JournalBritish journal of haematology (Br J Haematol) Vol. 142 Issue 4 Pg. 538-50 (Aug 2008) ISSN: 1365-2141 [Electronic] England
PMID18564361 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Biomarkers, Tumor
  • Tumor Suppressor Protein p53
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD (blood)
  • Biomarkers, Tumor (blood)
  • Cytogenetics
  • Female
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Interphase (genetics)
  • Lymphoma, Mantle-Cell (genetics, immunology, mortality)
  • Male
  • Middle Aged
  • Survival Analysis
  • Translocation, Genetic
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: